Compass Minerals
CMP
22.70
+0.13
+0.58%
Compass Minerals
US · CMP
#3284 by market cap
22.70
+0.13
+0.58%
Live - 5344 symbols - heartbeat 313s ago
· 2026-10-08 10:20
Pre-market
22.57
0.00%
After-hours
22.57
0.00%
- Market cap
- 952.97M
- P/E (TTM)i
- 54.05
- P/Bi
- 3.62
- EPSi
- -1.91
- Div yieldi
- 0.00%
- 52W posi
- 35%
Reader sentiment
Are you bullish or bearish on CMP?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.61, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +11.32% YoY
Margins
- Gross margin
- 15.33%
- Operating margin
- 6.35%
- Net margin
- -6.42%
Key ratios & quality
- Enterprise valuei
- 1.73B
- Altman Z-Scorei
- 1.61
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.08B | 1.09B | 1.00B | 836.20M | 1.25B | 1.20B | 1.12B | 1.24B |
| Gross profit | 183.90M | 232.50M | 219.80M | 170.00M | 199.80M | 232.00M | 195.00M | 190.70M |
| Selling & admin expenses | 104.40M | 112.90M | 116.80M | 92.20M | 133.50M | 150.20M | 137.80M | 113.30M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 79.50M | 119.60M | 103.00M | 77.80M | 45.40M | 77.40M | 74.20M | 79.00M |
| Pretax profit | 40.40M | 49.40M | 44.50M | 33.90M | 200.00K | 27.60M | -188.20M | -53.70M |
| Tax | 8.30M | 9.10M | 1.90M | 13.90M | 33.50M | 17.10M | 17.90M | 26.10M |
| Net profit | 64.80M | 60.80M | 63.10M | -213.80M | -21.10M | 10.50M | -206.10M | -79.80M |
| Basic EPS | 2 | 2 | 2 | -6 | -1 | 0 | -5 | -2 |
| Diluted EPS | 1.90 | 1.76 | 1.82 | -6.31 | -0.63 | 0.25 | -4.99 | -1.91 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 494.60M | 214.60M | 227.50M | 396.10M | 453.20M | 215.30M |
| Gross profit | 76.80M | 41.20M | 38.40M | 63.20M | 83.00M | 37.90M |
| Selling & admin expenses | 29.60M | 24.00M | 26.40M | 26.60M | 27.00M | 27.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 49.90M | 16.60M | 12.00M | 36.60M | 56.00M | 10.90M |
| Pretax profit | -22.20M | -13.60M | -4.00M | 16.40M | 28.70M | 700.00K |
| Tax | 9.80M | 3.40M | 3.20M | -2.20M | 16.00M | 6.40M |
| Net profit | -32.00M | -17.00M | -7.20M | 18.60M | 12.70M | -5.70M |
| Basic EPS | -1 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.77 | -0.41 | -0.17 | 0.43 | 0.30 | -0.13 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 721.20M | 780.00M | 756.30M | 531.40M | 570.90M | 600.90M | 587.30M | 572.20M |
| Cash & ST investments | 27.00M | 18.00M | 10.60M | 18.10M | 46.10M | 38.70M | 20.20M | 59.70M |
| Inventory | 266.60M | 228.70M | 298.70M | 321.70M | 313.30M | 399.50M | 414.10M | 312.00M |
| Total assets | 2.37B | 2.44B | 2.26B | 1.63B | 1.65B | 1.82B | 1.64B | 1.52B |
| Total current liabilities | 283.30M | 296.40M | 296.70M | 195.40M | 233.00M | 274.60M | 217.00M | 265.60M |
| Short-term debt | 43.50M | 10.00M | 10.00M | -- | -- | 5.00M | 12.70M | 7.90M |
| Long-term debt | 1.32B | 1.29B | 1.30B | 935.40M | 947.60M | 800.30M | 910.00M | 832.20M |
| Total liabilities | 1,827,700,000.00 | 1,920,500,000.00 | 1,883,200,000.00 | 1,337,800,000.00 | 1,387,200,000.00 | 1,295,900,000.00 | 1,323,500,000.00 | 1,285,300,000.00 |
| Total equity | 540.20M | 517.70M | 378.30M | 293.10M | 265.20M | 521.00M | 316.60M | 234.10M |
| Retained earnings | 643.50M | 595.60M | 559.10M | 272.40M | 235.30M | 220.90M | 2.20M | -77.60M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 565.30M | 570.60M | 572.20M | 632.20M | 508.10M | 499.10M |
| Cash & ST investments | 49.50M | 79.40M | 59.70M | 46.70M | 74.10M | 56.30M |
| Inventory | 220.70M | 264.70M | 312.00M | 258.40M | 178.70M | 257.20M |
| Total assets | 1.53B | 1.54B | 1.52B | 1.53B | 1.37B | 1.35B |
| Total current liabilities | 307.60M | 265.10M | 265.60M | 243.70M | 246.60M | 247.90M |
| Short-term debt | 10.00M | 7.20M | 7.90M | 6.90M | 6.40M | 20.70M |
| Long-term debt | 797.60M | 825.30M | 832.20M | 883.60M | 713.00M | 716.60M |
| Total liabilities | 1,295,400,000.00 | 1,287,600,000.00 | 1,285,300,000.00 | 1,266,200,000.00 | 1,091,100,000.00 | 1,090,000,000.00 |
| Total equity | 236.50M | 249.80M | 234.10M | 260.50M | 274.20M | 263.50M |
| Retained earnings | -53.40M | -70.40M | -77.60M | -59.00M | -46.30M | -52.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 182.30M | 159.60M | 175.20M | 154.70M | 120.40M | 106.00M | 14.40M | 197.70M |
| Depreciation & amortization | 136.90M | 137.90M | 137.90M | 94.90M | 112.80M | 98.60M | 105.00M | 103.20M |
| Free cash flow | 85.50M | 61.50M | 90.30M | 90.90M | 23.80M | -48.30M | -99.80M | 128.00M |
| Dividends paid | -97.70M | -98.10M | -99.10M | -73.10M | -20.80M | -24.90M | -12.60M | 0 |
| Stock buybacks / issuance | -- | -- | -- | 0 | 0 | 240.70M | 0 | 0 |
| Ending cash balance | 27.00M | 18.00M | 10.60M | 18.10M | 46.10M | 38.70M | 20.20M | 59.70M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 186.90M | 21.80M | -6.90M | -37.00M | 197.40M | 2.40M |
| Depreciation & amortization | 26.50M | 23.20M | 26.70M | 26.40M | 28.20M | 25.60M |
| Free cash flow | 172.90M | 3.80M | -22.80M | -59.80M | 179.20M | -18.70M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 49.50M | 79.40M | 59.70M | 46.70M | 74.10M | 56.30M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 11.06 | 11.48 | 12.70 | -69.57 | -9.24 | 3.93 | -49.48 | -28.98 |
| ROA %i | 2.77 | 2.55 | 2.47 | -11.33 | -1.55 | 0.88 | -11.93 | -5.05 |
| ROIC %i | 6.26 | 5.82 | 6.32 | -12.44 | 1.50 | 4.33 | -11.91 | -2.31 |
| 5-year avg ROE %i | 20.11 | 15.21 | 13.08 | -- | -- | -- | -- | -30.58 |
| EBIT margin %i | 9.38 | 10.27 | 10.37 | 9.35 | 4.25 | 7.34 | -10.62 | 1.19 |
| FCF / sales %i | 6.29 | 4.13 | 6.57 | 10.87 | 1.91 | -- | -- | 10.29 |
| Current ratioi | 2.55 | 2.63 | 2.55 | -- | 2.45 | 2.19 | 2.71 | 2.15 |
| Quick ratioi | 1.20 | 0.81 | 0.66 | -- | 0.92 | 0.61 | 0.67 | 0.90 |
| Debt / assetsi | 57.63 | 53.15 | 57.89 | -- | 57.35 | 44.32 | 56.94 | 55.79 |
| LT debt / equityi | 244.58 | 248.39 | 343.40 | -- | 357.32 | 153.61 | 290.97 | 358.74 |
| Interest coveragei | 2.24 | 2.24 | 2.00 | 1.77 | 0.96 | 1.59 | -1.71 | 0.22 |
| Revenue CAGR (3Y) %i | -0.59 | -1.57 | -9.69 | -8.87 | 5.13 | 6.82 | 10.15 | -0.03 |
| Net income CAGR (3Y) %i | -25.89 | -27.97 | 13.90 | -- | -- | -47.93 | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | 34.52 | 2.25 | -29.19 | -- | -- | 75.20 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -47.26 | -40.17 | -28.98 | -14.48 | 2.55 | 7.01 |
| ROA %i | -9.27 | -7.72 | -5.05 | -2.33 | 0.45 | 1.25 |
| ROIC %i | -7.97 | -5.72 | -2.31 | 1.35 | 4.63 | 5.42 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -2.19 | -2.46 | 1.19 | 3.47 | 7.52 | 8.49 |
| FCF / sales %i | 7.57 | 9.57 | 10.29 | 7.06 | 7.77 | 6.03 |
| Current ratioi | 1.84 | 2.15 | 2.15 | 2.59 | 2.06 | 2.01 |
| Quick ratioi | 1.05 | 1.06 | 0.90 | 1.33 | 1.21 | 0.83 |
| Debt / assetsi | 52.72 | 54.68 | 55.79 | 58.75 | 53.12 | 57.23 |
| LT debt / equityi | 337.25 | 333.63 | 358.74 | 341.65 | 262.18 | 286.11 |
| Interest coveragei | -0.37 | -0.43 | 0.22 | 0.66 | 1.40 | 1.62 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Salt is the largest reported line at 80.77% of revenue, across 3 reported segments.
- The next-largest line, Plant Nutrition, is a distant second at 19.04% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Salt80.77%
Plant Nutrition19.04%
Corporate & Other0.19%
Quote time 2026-10-08 10:20:58 · For reference only, not investment advice and not tailored to your situation.